MedTrace Logo

Bright Light Therapy for Post-COVID-19 Fatigue

NCT05677932 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-03-20

No results posted yet for this study

Summary

This is a randomized placebo-controlled trial to examine the efficacy of two-week bright light therapy for patients with post-COVID-19 fatigue.

Conditions

  • Post COVID-19 Condition

Interventions

DEVICE

Bright light therapy

Exposure to bright light therapy for 30mins a day for two weeks

DEVICE

Dim red light therapy

Exposure to 50lux dim red light therapy for 30mins a day for two weeks

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2024-02-28
Completion
2024-04-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05677932 on ClinicalTrials.gov